Investment Criteria

Royalty Pharma invests in revenue-producing intellectual property – principally, royalty interests in marketed and late stage development bio-pharmaceutical products. We work directly with research institutions, inventors and life science companies to assume the financial risks and rewards associated with ownership.

Royalty Pharma does not discover, develop, manufacture or market products. Our strategy is straightforward and simple: acquire royalty interests in leading pharmaceutical and biotechnology products and hold these interests as part of a diversified portfolio through expiration of the patent(s).


© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.